Haematologica

Haematologica Haematologica is a peer-reviewed medical journal covering clinical and experimental hematology. It publishes original research, reviews, guidelines, and correspondence on hematologic malignancies, inherited blood disorders, coagulation, and transplant-related science. The journal has served as a platform connecting clinicians and researchers across institutions such as Mayo Clinic, University of Cambridge, Memorial Sloan Kettering Cancer Center, Johns Hopkins Hospital, and Università di Milano.

History

Founded in 1920, the journal developed through interactions among European centers including Ospedale Maggiore Policlinico, Istituto Nazionale dei Tumori, and the Royal College of Physicians. During the interwar period contributions came from investigators affiliated with King's College London, Karolinska Institutet, and University of Paris, while wartime disruptions paralleled challenges experienced by journals like The Lancet and BMJ. Post-World War II expansion saw collaborations with North American institutions such as Harvard Medical School, University of Pennsylvania, and Stanford University School of Medicine. In the late 20th century, editorial leadership integrated advances from laboratories at Max Planck Society, Institut Pasteur, and Cold Spring Harbor Laboratory. The journal embraced digital publication practices concurrently with peers like New England Journal of Medicine and Nature Medicine, and aligned with initiatives promoted by organizations including Committee on Publication Ethics and International Committee of Medical Journal Editors.

Scope and Content

The journal's scope spans translational hematology, clinical trials, molecular pathogenesis, and therapeutic innovation. Typical topics include leukemia biology from groups at Fred Hutchinson Cancer Center, lymphoma therapeutics influenced by research at Dana–Farber Cancer Institute and University College London, myeloma studies reflecting work at University of Heidelberg, and coagulation research linked to investigators at Karolinska University Hospital. Hematopoietic stem cell transplantation reports often cite centers such as Fred Hutchinson Cancer Center and Karolinska Institutet, while genetic and genomic studies reference consortia like 1000 Genomes Project, International Cancer Genome Consortium, and HapMap. The journal has published consensus guidelines developed in cooperation with bodies such as European Hematology Association and American Society of Hematology, and features methodological advances influenced by technology from Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies.

Editorial Board and Publication Practices

Editorial leadership has included editors with affiliations to institutions like University of Milan, University of Oxford, University of California, San Francisco, and Catholic University of the Sacred Heart. The editorial board comprises clinicians and scientists from centers such as Memorial Sloan Kettering Cancer Center, Imperial College London, University of Toronto, Seoul National University Hospital, and Sydney Medical School. Peer review policies reflect standards advocated by Committee on Publication Ethics and indexing criteria from Clarivate Analytics. The journal uses single- or double-blind review models similar to those in Nature, with editorial decisions paralleling workflows at Cell Press journals. Open-access policies align with mandates from funders like European Research Council, National Institutes of Health, and Wellcome Trust, and article processing charges and waivers follow precedents set by publishers including Oxford University Press and Cambridge University Press.

Abstracting and Indexing

The journal is abstracted and indexed in major bibliographic services used by researchers at institutions like Harvard University, Yale University, Princeton University, University of Tokyo, and Peking University. Relevant databases include those curated by Clarivate Analytics for the Web of Science, the Scopus database operated by Elsevier, and repositories accessed through PubMed and MEDLINE at the National Library of Medicine. Bibliometric inclusion has facilitated discoverability alongside titles indexed in Embase and chemical and biological indices maintained by Elsevier and EBSCO. Abstracting partners mirror practices employed by journals included in lists maintained by Directory of Open Access Journals and global catalogues used by libraries such as the Library of Congress and the British Library.

Impact and Reception

The journal's impact has been reflected in citation metrics tracked by Clarivate Analytics and usage statistics monitored by academic institutions like Columbia University and University of Chicago. Articles published have influenced clinical practice guidelines from organizations such as European Society for Medical Oncology and National Comprehensive Cancer Network, and informed regulatory decisions by agencies like the European Medicines Agency and the U.S. Food and Drug Administration. High-profile papers cite collaborations among investigators at Dana–Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, M.D. Anderson Cancer Center, and University of Oxford. Reception in specialist communities is evidenced by discussions at conferences including American Society of Hematology Annual Meeting, European Hematology Association Congress, and American Association for Cancer Research Annual Meeting. The journal is compared with peer publications such as Blood (journal), Leukemia (journal), and British Journal of Haematology for niche influence within hematology.

Category:Hematology journals